Literature DB >> 2695942

Characterization of the spontaneous diabetes obesity syndrome in mature male CBA/Ca mice.

D M Connelly1, P V Taberner.   

Abstract

A spontaneous maturity onset diabetes obesity syndrome occurs in a small proportion (10-20%) of male CBA/Ca mice. Inbreeding can increase the incidence to 80%. It occurs at 12-16 weeks of age, and is characterized by hyperphagia, obesity, hyperglycaemia, hypertriglyceridaemia, hyperinsulinaemia, and an impaired glucose tolerance. The mice are also resistant to exogenous insulin. Female mice remain normal except for a slight increase in serum insulin. The male obese diabetic mice have a normal life expectancy. It is proposed that CBA/Ca mice can provide examples of a useful model for investigating the aetiology of type 2 diabetes and obesity, and the effectiveness of antidiabetic and antiobesity drugs.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2695942     DOI: 10.1016/0091-3057(89)90308-0

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  4 in total

1.  Sustained improvement in glucose homeostasis in lean and obese mice following chronic administration of the beta 3 agonist SR 58611A.

Authors:  C A Williams; M F Shih; P V Taberner
Journal:  Br J Pharmacol       Date:  1999-12       Impact factor: 8.739

2.  Regulation of cardiac adenylate cyclase activity in rodent models of obesity.

Authors:  D Strassheim; M D Houslay; G Milligan
Journal:  Biochem J       Date:  1992-04-01       Impact factor: 3.857

Review 3.  Acute and chronic animal models for the evaluation of anti-diabetic agents.

Authors:  Suresh Kumar; Rajeshwar Singh; Neeru Vasudeva; Sunil Sharma
Journal:  Cardiovasc Diabetol       Date:  2012-01-19       Impact factor: 9.951

4.  Strain specific behavioral and physiological responses to constant light in male CBA/J and CBA/CaJ mice.

Authors:  Hannah V Deane; Holly A Concepcion; Avery E Gatewood; Janessa Quintana; Joseph A Seggio
Journal:  Sleep Sci       Date:  2021 Apr-Jun
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.